Prostate Cancer - Results from #24260

Preoperative predictors of pathologic stage T2a and pathologic Gleason score ≤ 6 in men with clinical low-risk prostate cancer treated with radical prostatectomy: Reference for active surveillance - Abstract January 18, 2013

Opposing effects of androgen deprivation and targeted therapy on prostate cancer prevention - Abstract January 18, 2013

Current standards and future directions for prostate cancer radiation therapy - Abstract January 18, 2013

Screening for prostate cancer: An updated review - Abstract January 18, 2013

Comparison of surgical stress in patients undergoing open versus laparoscopic radical prostatectomy by measuring perioperative serum cytokine levels - Abstract January 18, 2013

Intrinsic religiousness as a mediator between fatalism and cancer-specific fear: Clarifying the role of fear in prostate cancer screening - Abstract January 18, 2013

Cancer mortality down 20% from 1991 peak January 18, 2013

Men at 'high' skeletal risk prior to prostate cancer hormone therapy likely to have more fractures after treatment January 18, 2013

Call for abstracts for the 2013 ASCO Annual Meeting January 17, 2013

Disparities in access to hospitals with robotic surgery for patients with prostate cancer undergoing radical prostatectomy - Abstract January 17, 2013

ASCO, ESMO, AUA, EAU, DGU - update urooncology: News with clinical relevance from major scientific meetings 2012 - Abstract January 17, 2013

Salvage hormonal therapy against recurrence after curative external beam radiotherapy for locally advanced prostate cancer at Kyoto University Hospital - Abstract January 17, 2013

Bladder neck preservation during classic laparoscopic radical prostatectomy - point of technique and preliminary results - Abstract January 17, 2013

Whole milk intake is associated with prostate cancer-specific mortality among U.S. male physicians - Abstract January 17, 2013

Neoadjuvant androgen deprivation therapy for prostate volume reduction, lower urinary tract symptom relief and quality of life improvement in men with intermediate- to high-risk prostate cancer: A randomised non-inferiority trial of degarelix versus goser January 17, 2013

Degarelix versus goserelin (+ antiandrogen flare protection) in the relief of lower urinary tract symptoms secondary to prostate cancer: Results from a phase IIIb study (NCT00831233) - Abstract January 17, 2013

Urinary tract-related quality of life after radical prostatectomy: Open retropubic versus robot-assisted laparoscopic approach - Abstract January 17, 2013

Risk stratification in prostate cancer screening - Abstract January 17, 2013

Recent trends in prostate cancer incidence by age, cancer stage, and grade, the United States, 2001-2007 - Abstract January 17, 2013

Diagnostic role of (18)F-FECH-PET/CT compared with bone scan in evaluating the prostate cancer patients referring with biochemical recurrence - Abstract January 17, 2013

Page 1214 of 1447